Skip to content

Drug interactions

Amlodipine-valsartan + Lomitapide

Severity: Moderate

Amlodipine-valsartan and Lomitapide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lomitapide is a sensitive CYP3A4 substrate, and weak CYP3A4 inhibitors such as amlodipine may raise its exposure. This increases the risk of hepatotoxicity and gastrointestinal adverse effects.

What this interaction means in plain words

Amlodipine-valsartan and Lomitapide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Amlodipine-valsartan belongs to Cardiovascular; Lomitapide belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Amlodipine weakly inhibits CYP3A4-mediated metabolism of lomitapide.

What to do

Limit the lomitapide dose to no more than 30 mg daily when given with weak CYP3A4 inhibitors. Monitor liver enzymes as per lomitapide labeling.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Amlodipine-valsartan and Lomitapide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Amlodipine-valsartan with Lomitapide?

MediHelp rates the interaction as moderate. Amlodipine-valsartan and Lomitapide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lomitapide is a sensitive CYP3A4 substrate, and weak CYP3A4 inhibitors such as amlodipine may raise its exposure. This increases the risk of hepatotoxicity and gastrointestinal adverse effects.

How serious is the interaction between Amlodipine-valsartan and Lomitapide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Limit the lomitapide dose to no more than 30 mg daily when given with weak CYP3A4 inhibitors. Monitor liver enzymes as per lomitapide labeling.

What other medicines interact with Amlodipine-valsartan?

MediHelp also lists interactions of Amlodipine-valsartan with, for example, Aliskiren, Sparsentan, Aldesleukin. The full list is on the Amlodipine-valsartan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in